Furthermore, in our current complementary study, we found that DRD2 activation inhibited acinar cell necroptosis both in vitro and in vivo, which provides a new theoretical basis for elucidating AP treatment with DRD2 agonist. Here, DRD2 is linked to alkaline phosphatase measurement.